Role of baseline 68Ga-PSMA PET/CT-derived whole-body volumetric parameters in predicting survival outcomes of metastatic castration-resistant prostate cancer patients receiving first-line treatment.
Saved in:
| Title: | Role of baseline 68Ga-PSMA PET/CT-derived whole-body volumetric parameters in predicting survival outcomes of metastatic castration-resistant prostate cancer patients receiving first-line treatment. |
|---|---|
| Authors: | Telli TA; Division of Medical Oncology, School of Medicine, Marmara University, Istanbul, 34899, Turkey. tugbaakintelli@gmail.com., Ozguven S; Department of Nuclear Medicine, School of Medicine, Marmara University, Istanbul, 34899, Turkey., Alan O; Division of Medical Oncology, School of Medicine, Marmara University, Istanbul, 34899, Turkey.; Division of Medical Oncology, School of Medicine, Koç University, Istanbul, Turkey., Filizoglu N; Department of Nuclear Medicine, School of Medicine, Marmara University, Istanbul, 34899, Turkey., Ozturk MA; Division of Medical Oncology, School of Medicine, Marmara University, Istanbul, 34899, Turkey., Sariyar N; Department of Internal Medicine, School of Medicine, Marmara University, Istanbul, 34899, Turkey., Isik S; Division of Medical Oncology, School of Medicine, Marmara University, Istanbul, 34899, Turkey., Arikan R; Division of Medical Oncology, School of Medicine, Marmara University, Istanbul, 34899, Turkey., Demircan NC; Division of Medical Oncology, School of Medicine, Marmara University, Istanbul, 34899, Turkey., Basoglu T; Division of Medical Oncology, School of Medicine, Marmara University, Istanbul, 34899, Turkey., Cetin IA; Department of Radiation Oncology, School of Medicine, Marmara University, Istanbul, 34899, Turkey., Ones T; Department of Nuclear Medicine, School of Medicine, Marmara University, Istanbul, 34899, Turkey., Ercelep O; Division of Medical Oncology, School of Medicine, Marmara University, Istanbul, 34899, Turkey., Dane F; Division of Medical Oncology, School of Medicine, Marmara University, Istanbul, 34899, Turkey., Yumuk PF; Division of Medical Oncology, School of Medicine, Marmara University, Istanbul, 34899, Turkey.; Division of Medical Oncology, School of Medicine, Koç University, Istanbul, Turkey. |
| Source: | Annals of nuclear medicine [Ann Nucl Med] 2022 Nov; Vol. 36 (11), pp. 964-975. Date of Electronic Publication: 2022 Aug 23. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Japan Country of Publication: Japan NLM ID: 8913398 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1864-6433 (Electronic) Linking ISSN: 09147187 NLM ISO Abbreviation: Ann Nucl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35997890 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Role of baseline <superscript>68</superscript>Ga-PSMA PET/CT-derived whole-body volumetric parameters in predicting survival outcomes of metastatic castration-resistant prostate cancer patients receiving first-line treatment. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Telli+TA%22">Telli TA</searchLink>; Division of Medical Oncology, School of Medicine, Marmara University, Istanbul, 34899, Turkey. tugbaakintelli@gmail.com.<br /><searchLink fieldCode="AU" term="%22Ozguven+S%22">Ozguven S</searchLink>; Department of Nuclear Medicine, School of Medicine, Marmara University, Istanbul, 34899, Turkey.<br /><searchLink fieldCode="AU" term="%22Alan+O%22">Alan O</searchLink>; Division of Medical Oncology, School of Medicine, Marmara University, Istanbul, 34899, Turkey.; Division of Medical Oncology, School of Medicine, Koç University, Istanbul, Turkey.<br /><searchLink fieldCode="AU" term="%22Filizoglu+N%22">Filizoglu N</searchLink>; Department of Nuclear Medicine, School of Medicine, Marmara University, Istanbul, 34899, Turkey.<br /><searchLink fieldCode="AU" term="%22Ozturk+MA%22">Ozturk MA</searchLink>; Division of Medical Oncology, School of Medicine, Marmara University, Istanbul, 34899, Turkey.<br /><searchLink fieldCode="AU" term="%22Sariyar+N%22">Sariyar N</searchLink>; Department of Internal Medicine, School of Medicine, Marmara University, Istanbul, 34899, Turkey.<br /><searchLink fieldCode="AU" term="%22Isik+S%22">Isik S</searchLink>; Division of Medical Oncology, School of Medicine, Marmara University, Istanbul, 34899, Turkey.<br /><searchLink fieldCode="AU" term="%22Arikan+R%22">Arikan R</searchLink>; Division of Medical Oncology, School of Medicine, Marmara University, Istanbul, 34899, Turkey.<br /><searchLink fieldCode="AU" term="%22Demircan+NC%22">Demircan NC</searchLink>; Division of Medical Oncology, School of Medicine, Marmara University, Istanbul, 34899, Turkey.<br /><searchLink fieldCode="AU" term="%22Basoglu+T%22">Basoglu T</searchLink>; Division of Medical Oncology, School of Medicine, Marmara University, Istanbul, 34899, Turkey.<br /><searchLink fieldCode="AU" term="%22Cetin+IA%22">Cetin IA</searchLink>; Department of Radiation Oncology, School of Medicine, Marmara University, Istanbul, 34899, Turkey.<br /><searchLink fieldCode="AU" term="%22Ones+T%22">Ones T</searchLink>; Department of Nuclear Medicine, School of Medicine, Marmara University, Istanbul, 34899, Turkey.<br /><searchLink fieldCode="AU" term="%22Ercelep+O%22">Ercelep O</searchLink>; Division of Medical Oncology, School of Medicine, Marmara University, Istanbul, 34899, Turkey.<br /><searchLink fieldCode="AU" term="%22Dane+F%22">Dane F</searchLink>; Division of Medical Oncology, School of Medicine, Marmara University, Istanbul, 34899, Turkey.<br /><searchLink fieldCode="AU" term="%22Yumuk+PF%22">Yumuk PF</searchLink>; Division of Medical Oncology, School of Medicine, Marmara University, Istanbul, 34899, Turkey.; Division of Medical Oncology, School of Medicine, Koç University, Istanbul, Turkey. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228913398%22">Annals of nuclear medicine</searchLink> [Ann Nucl Med] 2022 Nov; Vol. 36 (11), pp. 964-975. <i>Date of Electronic Publication: </i>2022 Aug 23. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Japan%22">Springer Japan </searchLink><i>Country of Publication: </i>Japan <i>NLM ID: </i>8913398 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1864-6433 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209147187%22">09147187 </searchLink><i>NLM ISO Abbreviation: </i>Ann Nucl Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35997890 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s12149-022-01785-x Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 964 Titles: – TitleFull: Role of baseline 68Ga-PSMA PET/CT-derived whole-body volumetric parameters in predicting survival outcomes of metastatic castration-resistant prostate cancer patients receiving first-line treatment. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Telli TA – PersonEntity: Name: NameFull: Ozguven S – PersonEntity: Name: NameFull: Alan O – PersonEntity: Name: NameFull: Filizoglu N – PersonEntity: Name: NameFull: Ozturk MA – PersonEntity: Name: NameFull: Sariyar N – PersonEntity: Name: NameFull: Isik S – PersonEntity: Name: NameFull: Arikan R – PersonEntity: Name: NameFull: Demircan NC – PersonEntity: Name: NameFull: Basoglu T – PersonEntity: Name: NameFull: Cetin IA – PersonEntity: Name: NameFull: Ones T – PersonEntity: Name: NameFull: Ercelep O – PersonEntity: Name: NameFull: Dane F – PersonEntity: Name: NameFull: Yumuk PF IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: 2022 Nov Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1864-6433 Numbering: – Type: volume Value: 36 – Type: issue Value: 11 Titles: – TitleFull: Annals of nuclear medicine Type: main |
| ResultId | 1 |